Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: Implications for the development of a refined staging system

HPB

Volumn 15, Issue 6, 2013, Pages 439-448

  Chan, Albert C Y ^a   Fan, Sheung Tat ^a   Poon, Ronnie T P ^a   Cheung, Tan To ^a   Chok, Kenneth S H ^a   Chan, See Ching ^a   Lo, Chung Mau ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; TUMOR INVASION; TUMOR VOLUME; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; EVALUATION STUDY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LYMPH NODE; LYMPH NODE METASTASIS; MEDICAL SOCIETY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIETIES, MEDICAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877714752     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00617.x     Document Type: Article

References (30)

1. Bosch FX, Ribes J, Borras J,. (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285. (Pubitemid 29488770)
2. Sherman M,. (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25: 143-154. (Pubitemid 40781067)
3. Nordenstedt H, White DL, El-Serag HB,. (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42 (Suppl. 3): 206-214.
4. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, et al. (2001) Clinicopathologic features of longterm survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19: 3037-3044. (Pubitemid 32565441)
5. Kaibori M, Ishizaki M, Saito T, Matsui K, Kwon AH, Kamiyama Y,. (2009) Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas. Am J Surg 198: 39-45.
6. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. (2008) Neither multiple tumours nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134: 1908-1916. (Pubitemid 351783260)
7. Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y, et al. (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17: 2740-2746.
8. Sasaki Y, Yamada T, Tanaka H, Ohigashi H, Eguchi H, Yano M, et al. (2006) Risk of recurrence in a longterm follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 244: 771-780. (Pubitemid 44629952)
9. Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T,. (2003) AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB 5: 243-250. (Pubitemid 38008080)
10. Japan Liver Cancer Study Group. (2000) General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 4th Japanese edn. Tokyo: Kanehara.
11. Japan Liver Cancer Study Group. (2003) General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd English edn. Tokyo: Kanehara.
12. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536. (Pubitemid 34260532)
13. Nathan H, Mentha G, Marques HP, Capussotti L, Majno P, Aldrighetti L, et al. (2009) Comparative performances of staging systems for early hepatocellular carcinoma. HPB 11: 382-390.
14. Edge SB, ed. (2009) Liver. In: AJCC Cancer Staging Manual, 7th edn. New York, NY: Springer, pp. 201-210.
15. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M,. (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13 772 patients in Japan. Ann Surg 245: 909-922. (Pubitemid 46809293)
16. Poon RT, Fan ST,. (2003) Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 12: 35-50. (Pubitemid 36204978)
17. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, et al. (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253: 745-758.
18. Kobayashi S, Takahashi S, Kato Y, Gotohda N, Nakagohri T, Konishi M, et al. (2011) Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18: 559-566.
19. Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L, Ren N, et al. (2007) Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 96: 37-45. (Pubitemid 47015447)
20. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, et al. (2004) The role of lymphadenectomy for liver tumours: further considerations on the appropriateness of treatment strategy. Ann Surg 239: 202-209. (Pubitemid 38176354)
21. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106: 720-727. (Pubitemid 24064340)
22. Li B, Yuan Y, Chen G, He L, Zhang Y, Li J, et al. (2010) Application of tumour-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? BMC Cancer 10: 535.
23. Choi KK, Kim SH, Choi SB, Lim JH, Choi GH, Choi JS, et al. (2011) Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 26: 1646-1651.
24. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J,. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89: 500-507. (Pubitemid 30640096)
25. Liu CL, Fan ST, Lo CM, Tso WK, Poon RT, Lam CM, et al. (2001) Management of spontaneous rupture of hepatocellular carcinoma: single-centre experience. J Clin Oncol 19: 3725-3732.
26. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, et al. (2005) Comparison of recurrence after hepatic resection in patients with hepatitis B versus hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 25: 236-241.
27. Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC,. (2011) A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg 35: 858-867.
28. Tanaka S, Mogushi K, Yasen M, Noguchi N, Kudo A, Kurokawa T, et al. (2009) Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma. J Am Coll Surg 208: 368-374.
29. Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N,. (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95: 1294-1300. (Pubitemid 30263527)
30. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, et al. (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249: 617-623.